Healthcare Economics & Policy

The FDA on Oct. 15 issued a warning letter to India-based Torrent Pharmaceuticals, targeting the drug company as one of the primary contributors to the onslaught of BP drug recalls in the past year.

The global market for implantable pacemakers is projected to see moderate, steady growth through 2023, resulting in a sum of more than $5.32 billion, according to a recent report.

A drop in income over six years was linked to a higher likelihood of CVD in a recent analysis of the ARIC study, suggesting financial stress might be a predictor of worse heart health in the U.S.

The CDC released updated statistics and a new framework for identifying, diagnosing and treating e-cigarette or vaping-related lung disease Oct. 11, putting a name to the recent phenomenon in the process.

Consumer watchdog group U.S. PIRG is criticizing the FDA for “missing their timeline” to review potentially carcinogenic blood pressure medications like losartan, valsartan and irbesartan, arguing the agency needs to step up its efforts to ensure pharmaceutical companies are distributing safe drugs.

Recent pushback against a nutritional guideline that supports the consumption of red and processed meats includes allegations that the guideline’s lead author had ties to the meat industry, Health Exec reports.

Presidential hopeful Sen. Bernie Sanders suffered a heart attack last week, his campaign confirmed Oct. 4.

Vermont senator and presidential hopeful Bernie Sanders was hospitalized Tuesday for an artery blockage that required two stents, the New York Times reports.

An economic analysis of COAPT data suggests edge-to-edge TMVR with the MitraClip device is a more affordable long-term treatment option than guideline-directed medical therapy alone for patients with severe secondary MR—but the steep cost of an index TMVR procedure might eclipse that benefit.

Cardiologist John Stobeck, accused of inappropriately touching a female patient during a medical exam in 2012, headed to trial on Tuesday, the North Jersey Record reports.

Torrent Pharmaceuticals Limited is the latest drug company to issue a recall of losartan potassium, a popular blood pressure drug that’s been under scrutiny for more than a year for containing probable human carcinogens.

North Carolina Children’s Hospital has received the go-ahead from an external advisory board to resume complex heart surgeries after a New York Times investigation ground the program to a halt three months ago, the Times reports.